News
Pharma News Update September 2020
COVID-19 Vaccine Development AstraZeneca Under Fire for COVID-19 Vaccine Safety, Releases Trial Protocol Following scrutiny over a potential patient side effect that prompted a clinical hold of its Phase III [...]
Pharma News Update August 2020
COVID-19 Vaccine Development EC Signs COVID-19 Vaccine Contract with AstraZeneca On 27th Aug 2020, the European Commission (EC) announced that it had signed its first contract with AstraZeneca for the [...]
Regulatory News Update August 2020
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) Update on MHRA Regulatory Flexibilities Resulting from Coronavirus (COVID-19) Guidance The update on the Guidance was published on 4th August 2020. The MHRA [...]
OECD Advisory Document on GLP Data Integrity
On 07 August 2020, the OECD made available their long-awaited OECD Draft Advisory Document on GLP Data Integrity for public comment. The document gives guidance on; the responsibilities from data [...]
MHRA GCP Guidance for Clinical Trials
On 31st July 2020 MHRA updated “Good clinical practice for clinical trials” on their website available here. Guidance for the notification of serious breaches of GCP or the trial protocol, [...]
Pharma News Update July 2020
COVID-19 Vaccine Development Dynavax and Medigen Announce Partnership for a Novel Adjuvanted COVID-19 Vaccine Candidate On 23rd July 2020, Dynavax Technologies, a biopharmaceutical company focused on developing and commercialising novel [...]
Regulatory News Update July 2020
Medicines and Healthcare products Regulatory Agency (MHRA) Updates on MHRA Regulatory Flexibilities resulting from Coronavirus (COVID-19) guidelines The MHRA issued additional updates to the guidelines in July 2020. Information for [...]
Our New Training Courses
Tower Mains is pleased to announce training courses to help you, your employees and colleagues stay up to date with the latest practices, standards and guidelines are now on our [...]
A comparison of the EMA, FDA and MHRA guidance on the conduct of clinical trials during the COVID-19 pandemic
Printed in July's 2020 issue of RQA's Quasar Global regulatory authorities acknowledge the impact and increasing pressure that the COVID-19 pandemic is putting on global health care systems. Against this [...]
Introducing Tower Mains and a new website
Who are we? Tower Mains Ltd was first established in 2001 as an independent Research Quality Assurance consultancy that became widely known as TMQA. Our core business was conducting audits [...]
